Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Department of Radiation Oncology, Emory University, Atlanta, Georgia, United States of America.
Phys Med Biol. 2024 Oct 23;69(21). doi: 10.1088/1361-6560/ad84b6.
With advancements in high-dose rate brachytherapy, the clinical translation of intensity modulated brachytherapy (IMBT) innovations necessitates utilization of model-based dose calculation algorithms (MBDCA) for accurate and rapid dose calculations. This study uniquely benchmarks a commercial MBDCA, BrachyVision ACUROS(BVA), against Monte Carlo (MC) simulations, evaluating dose distributions for a novel IMBT applicator, termed as theDirection Modulated Brachytherapy (DMBT) tandem, expanding beyond previous focus on partially shielded vaginal cylinder applicators, through a novel methodology.The DMBT tandem applicator, made of a tungsten alloy with six evenly spaced grooves, was simulated using the GEANT4 MC code. Subsequently, two main scenarios were created using the BVA and reproduced by the MC simulations: '' and '' for three cubical virtual water phantoms (20 cm), (30 cm), and (40 cm). A track length estimator was utilized for dose calculation and 2D/3D scoring were performed. The difference in isodose surfaces/lines (i.e. coverage) at each voxel,, was thus calculated for relevant normalization points ().The coverage was comparable, based on 2D scoring, between the BVA and MC isodose surfaces/lines for the region of clinical relevance, (i.e. within 5 cm radius from the source) with(: 1 cm from the source) falling within 2% for the two scenarios for all phantom sizes. For the phantom (20 cm),(3D scoring) recorded the range [-3.0% +6.5%] ([-7.4% +7.3%]) for 95% of the voxels of the same scoring volume for the SACWP (SAMA) scenario.The results indicated that the BVA could render comparable coverage as compared to the MC simulations in the region of clinical relevance for different phantom sizes.may offer an advantageous metric for evaluation of MBDCAs in clinical setting.
随着高剂量率近距离放射治疗的进步,强度调制近距离放射治疗(IMBT)创新的临床转化需要利用基于模型的剂量计算算法(MBDCA)进行准确快速的剂量计算。本研究通过一种新颖的方法,将商业 MBDCA(BrachyVision ACUROS(BVA))与蒙特卡罗(MC)模拟进行基准测试,评估一种新型 IMBT 施源器的剂量分布,称为方向调制近距离放射治疗(DMBT)施源器,超出了之前对部分屏蔽阴道圆柱施源器的关注,通过一种新颖的方法。DMBT 施源器由钨合金制成,带有六个均匀间隔的凹槽,使用 GEANT4 MC 代码进行模拟。随后,使用 BVA 创建了两个主要场景,并通过 MC 模拟进行了再现:对于三个立方虚拟水体模(20cm)、(30cm)和(40cm),创建了“”和“”。使用轨迹长度估计器进行剂量计算,并进行了 2D/3D 评分。因此,为相关归一化点()计算了每个体素处等剂量面/线(即覆盖)的差异。在临床相关区域(即距源 5cm 半径内),基于 2D 评分,BVA 和 MC 等剂量面/线之间的覆盖情况相当,对于所有体模尺寸的两个场景,(距源 1cm 处)均在 2%以内。对于体模(20cm),(3D 评分)记录了 SACWP(SAMA)场景中相同评分体积的 95%体素的范围为[-3.0%+6.5%]([-7.4%+7.3%])。结果表明,BVA 可以在不同体模尺寸的临床相关区域提供与 MC 模拟相当的覆盖范围。可以为评估临床环境中的 MBDCA 提供有利的指标。